Cargando…

Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT™ adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice

The speed at which several COVID-19 vaccines went from conception to receiving FDA and EMA approval for emergency use is an achievement unrivaled in the history of vaccine development. Mass vaccination efforts using the highly effective vaccines are currently underway to generate sufficient herd imm...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Chih-Yun, To, Albert, Wong, Teri Ann S., Lieberman, Michael M., Clements, David E., Senda, James T., Ball, Aquena H., Pessaint, Laurent, Andersen, Hanne, Furuyama, Wakako, Marzi, Andrea, Donini, Oreola, Lehrer, Axel T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Regular paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8570651/ https://www.ncbi.nlm.nih.gov/pubmed/34778744 http://dx.doi.org/10.1016/j.jvacx.2021.100126

Ejemplares similares

CoVaccine HT™ Adjuvant Potentiates Robust Immune Responses to Recombinant SARS-CoV-2 Spike S1 Immunization
por: Haun, Brien K., et al.
Publicado: (2020)

Safety and immunogenicity of multi-antigen AMA1-based vaccines formulated with CoVaccine HT™ and Montanide ISA 51 in rhesus macaques
por: Kusi, Kwadwo A, et al.
Publicado: (2011)

Maternal Immunization Using a Protein Subunit Vaccine Mediates Passive Immunity against Zaire ebolavirus in a Murine Model
por: Williams, Caitlin A., et al.
Publicado: (2022)

An Empirical Approach towards the Efficient and Optimal Production of Influenza-Neutralizing Ovine Polyclonal Antibodies Demonstrates That the Novel Adjuvant CoVaccine HT™ Is Functionally Superior to Freund's Adjuvant
por: Stevens, Natalie E., et al.
Publicado: (2013)

VSV-Based Vaccines Reduce Virus Shedding and Viral Load in Hamsters Infected with SARS-CoV-2 Variants of Concern
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

The vesicular stomatitis virus-based Ebola virus vaccine: From concept to clinical trials
por: Suder, Ellen, et al.
Publicado: (2018)

Development of an Enzyme-Linked Immunosorbent Assay to Determine the Expression Dynamics of Ebola Virus Soluble Glycoprotein during Infection
por: Furuyama, Wakako, et al.
Publicado: (2020)

Durable Immunity to Ricin Toxin Elicited by a Thermostable, Lyophilized Subunit Vaccine
por: Novak, Hayley, et al.
Publicado: (2021)

Trivalent SARS-CoV-2 S1 Subunit Protein Vaccination Induces Broad Humoral Responses in BALB/c Mice
por: Khan, Muhammad S., et al.
Publicado: (2023)

A Recombinant Subunit Based Zika Virus Vaccine Is Efficacious in Non-human Primates
por: Medina, Liana O., et al.
Publicado: (2018)

Optimization of single dose VSV-based COVID-19 vaccination in hamsters
por: O’Donnell, Kyle L., et al.
Publicado: (2021)

Optimization of Single-Dose VSV-Based COVID-19 Vaccination in Hamsters
por: O’Donnell, Kyle L., et al.
Publicado: (2022)

The Ebola virus soluble glycoprotein contributes to viral pathogenesis by activating the MAP kinase signaling pathway
por: Furuyama, Wakako, et al.
Publicado: (2021)

A single dose of a vesicular stomatitis virus-based influenza vaccine confers rapid protection against H5 viruses from different clades
por: Furuyama, Wakako, et al.
Publicado: (2020)

Broad humoral and cellular immunity elicited by one-dose mRNA vaccination 18 months after SARS-CoV-2 infection
por: Kang, Chang Kyung, et al.
Publicado: (2022)

A polyvalent virosomal influenza vaccine induces broad cellular and humoral immunity in pigs
por: Haach, Vanessa, et al.
Publicado: (2023)

Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine
por: Peng, Pai, et al.
Publicado: (2021)

Humoral and adaptive immune responses to the SARS-CoV-2 vaccine
por: Rizzo, Roberta, et al.
Publicado: (2022)

Multiple Routes of Antibody-Dependent Enhancement of SARS-CoV-2 Infection
por: Okuya, Kosuke, et al.
Publicado: (2022)

Humoral response to mRNA vaccines against SARS-CoV-2 in patients with humoral immunodeficiency disease
por: Bitzenhofer, Michaela, et al.
Publicado: (2022)

A complement component C1q-mediated mechanism of antibody-dependent enhancement of Ebola virus infection
por: Furuyama, Wakako, et al.
Publicado: (2020)

Ebola Virus Glycoprotein Domains Associated with Protective Efficacy
por: Bhatia, Bharti, et al.
Publicado: (2021)

Vocal fold palsy after vaccination against SARS-CoV-2()
por: Lehrer, Eduardo, et al.
Publicado: (2022)

Humoral response to SARS-CoV-2 vaccines in people living with HIV
por: Noe, Sebastian, et al.
Publicado: (2021)

SARS-CoV-2 vaccine humoral response in adults with Down syndrome
por: Sali, Michela, et al.
Publicado: (2022)

Cellular and humoral responses to SARS-CoV-2 vaccination in immunosuppressed patients
por: Mohanraj, Dinesh, et al.
Publicado: (2022)

Humoral Immune Response to SARS-CoV-2 Vaccination in MS Patients
por: Oreja-Guevara, Celia, et al.
Publicado: (2022)

Impact of rituximab on humoral response to SARS-CoV-2 vaccination in previously vaccinated patients with autoimmune diseases
por: Oliosi, E., et al.
Publicado: (2023)

Rapid protection from COVID-19 in nonhuman primates vaccinated intramuscularly but not intranasally with a single dose of a recombinant vaccine
por: Furuyama, Wakako, et al.
Publicado: (2021)

Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression
por: Prendecki, Maria, et al.
Publicado: (2021)

Humoral immunity to SARS-CoV-2 vaccination in haemodialysis patients—Authors´ Reply
por: Stumpf, Julian, et al.
Publicado: (2021)

Humoral immune response after different SARS-CoV-2 vaccination regimens
por: Rose, Ruben, et al.
Publicado: (2022)

Humoral response to inactivated SARS-CoV-2 vaccines in patients on sirolimus alone
por: Cheng, Chongsheng, et al.
Publicado: (2022)

Humoral response to vaccination against SARS-CoV-2 in patients undergoing dialysis
por: Lee, Yoo Jin, et al.
Publicado: (2022)

Declined Humoral Immunity of Kidney Transplant Recipients to SARS-CoV-2 Vaccines
por: Mahallawi, Waleed H, et al.
Publicado: (2023)

Humoral Response after SARS-CoV-2 Vaccination in Prostate Cancer Patients
por: Błaszczuk, Agata, et al.
Publicado: (2023)

Superior humoral immunity in vaccinated SARS-CoV-2 convalescence as compared to SARS-COV-2 infection or vaccination
por: Paniskaki, Krystallenia, et al.
Publicado: (2022)

Assessment of Broadly Reactive Responses in Patients With MERS-CoV Infection and SARS-CoV-2 Vaccination
por: Zedan, Hadeel T., et al.
Publicado: (2023)

Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine
por: Furuyama, Wakako, et al.
Publicado: (2022)

Role of Immunosuppression on Efficacy of Anti-SARS-CoV-2 Vaccines in Heart Transplanted (HT) Patients
por: Masetti, M., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3kvteov0kaoff7hrdb12srhiav